Concepedia

Publication | Open Access

Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis

DOIFull Paper Access

145

Citations

19

References

2024

Year

Michael E. Wechsler, Parameswaran Nair, Benjamin Terrier, Bastian Walz, Arnaud Bourdin, David Jayne, David J. Jackson, Florence Roufosse, Lena Börjesson Sjö, Ying Fan,
New England Journal of Medicine

Abstract

Benralizumab was noninferior to mepolizumab for the induction of remission in patients with relapsing or refractory EGPA. (Funded by AstraZeneca; MANDARA ClinicalTrials.gov number, NCT04157348.).

References

YearCitations

Page 1